Research work · 2020

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder

Cell

Download PDF

DOI: 10.1016/j.cell.2020.02.052